Borgwardt S

University of Luebeck, Department of Psychiatry and Psychotherapy, Luebeck, Germany.

20 papers · 2 preprints · ORCID

ArticleLSD

Neuroplastic white matter changes in patients with major depression following lysergic acid diethylamide treatment.

Avram M, Menegaux A, Müller F +7

Europe PMC2026
PreprintPsilocybin

Psychedelics distinctly alter brain entropy and complexity compared to psychostimulants

Larsen K, Fisher PM, McCulloch DE +11

Europe PMC2026
ArticlePsychedelics

Psychedelics for major depression-From controlled research settings into broader clinical use.

Avram M, Borgwardt S

Europe PMC2025
ArticleLSD

Efficacy and safety of low- versus high-dose-LSD-assisted therapy in patients with major depression: A randomized trial.

Müller F, Zaczek H, Becker AM +8

Europe PMC2025
ArticleMDMA

Large-scale brain connectivity changes following the administration of lysergic acid diethylamide, d-amphetamine, and 3,4-methylenedioxyamphetamine.

Avram M, Fortea L, Wollner L +10

Europe PMC2025
ArticleMDMA

Effective Connectivity of Thalamocortical Interactions Following d-Amphetamine, LSD, and MDMA Administration.

Avram M, Müller F, Preller KH +8

Europe PMC2024
ArticleLSD

The effect of lysergic acid diethylamide (LSD) on whole-brain functional and effective connectivity.

Bedford P, Hauke DJ, Wang Z +9

Europe PMC2023
PreprintLSD

The effect of lysergic acid diethylamide (LSD) on whole-brain functional and effective connectivity

Bedford P, Hauke DJ, Wang Z +9

Europe PMC2022
ArticleMDMA

Characterizing Thalamocortical (Dys)connectivity Following D-Amphetamine, LSD, and MDMA Administration.

Avram M, Müller F, Rogg H +7

Europe PMC2022
ArticlePsilocybin

Flashback phenomena after administration of LSD and psilocybin in controlled studies with healthy participants.

Müller F, Kraus E, Holze F +6

Europe PMC2022
ArticlePsychedelics

Bridging the Gap? Altered Thalamocortical Connectivity in Psychotic and Psychedelic States.

Avram M, Rogg H, Korda A +3

Europe PMC2021
ArticleMDMA

MDMA-induced changes in within-network connectivity contradict the specificity of these alterations for the effects of serotonergic hallucinogens.

Müller F, Holze F, Dolder P +5

Europe PMC2021
ArticleLSD

Treatment of a Complex Personality Disorder Using Repeated Doses of LSD-A Case Report on Significant Improvements in the Absence of Acute Drug Effects.

Müller F, Mühlhauser M, Holze F +4

Europe PMC2020
ArticleLSD

Acute dose-dependent effects of lysergic acid diethylamide in a double-blind placebo-controlled study in healthy subjects.

Holze F, Vizeli P, Ley L +8

Europe PMC2021
ArticlePsilocybin

Editorial: Hallucinogens and Entactogens: Establishing a New Class of <i>Psychotherapeutic</i> Drugs?

Müller F, Johnson MW, Borgwardt S

Europe PMC2020
ArticleMDMA

Distinct acute effects of LSD, MDMA, and D-amphetamine in healthy subjects.

Holze F, Vizeli P, Müller F +6

Europe PMC2020
ArticleLSD

Acute effects of lysergic acid diethylamide (LSD) on resting brain function.

Müller F, Borgwardt S

Europe PMC2019
ArticlePsilocybin

Advances and challenges in neuroimaging studies on the effects of serotonergic hallucinogens: Contributions of the resting brain.

Müller F, Liechti ME, Lang UE +1

Europe PMC2018
ArticleLSD

Altered network hub connectivity after acute LSD administration.

Müller F, Dolder PC, Schmidt A +2

Europe PMC2018
ArticleLSD

Increased thalamic resting-state connectivity as a core driver of LSD-induced hallucinations.

Müller F, Lenz C, Dolder P +4

Europe PMC2017
ArticleLSD

Acute effects of LSD on amygdala activity during processing of fearful stimuli in healthy subjects.

Mueller F, Lenz C, Dolder PC +5

Europe PMC2017
ArticleLSD

LSD Acutely Impairs Fear Recognition and Enhances Emotional Empathy and Sociality.

Dolder PC, Schmid Y, Müller F +2

Europe PMC2016